5-Aminolevulinate (ALA) patches with red light (630-nm light source and a total light dose of 37 J/cm2) is an effective treatment indicated by food and drug administration (FDA) and european medicines agency (EMA) only for grade I to II actinic keratosis located on the scalp and face. Currently, there are no efficacy data on their use in the treatment of other types of epithelial neoplasms. We analyzed the efficacy of ALA patches in seven superficial basal cell carcinomas (sBCCs) that occurred in four patients. All lesions were treated with topical ALA patches. A complete response of all sBCCs was achieved at week 24 after treatment. Our study suggests that ALA patches for sBCCs have good efficacy rates and excellent safety profile.

De Luca, E. V., Tambone, S., Catapano, S., Fossati, B., Peris, K., Photodynamic therapy with 5-aminolevulinate patch for the treatment of superficial basal cell carcinomas, <<DERMATOLOGIC THERAPY>>, 2020; 33 (6): e14518-N/A. [doi:10.1111/dth.14518] [http://hdl.handle.net/10807/168702]

Photodynamic therapy with 5-aminolevulinate patch for the treatment of superficial basal cell carcinomas

De Luca E. V.;Catapano S.;Fossati B.;Peris K.
2020

Abstract

5-Aminolevulinate (ALA) patches with red light (630-nm light source and a total light dose of 37 J/cm2) is an effective treatment indicated by food and drug administration (FDA) and european medicines agency (EMA) only for grade I to II actinic keratosis located on the scalp and face. Currently, there are no efficacy data on their use in the treatment of other types of epithelial neoplasms. We analyzed the efficacy of ALA patches in seven superficial basal cell carcinomas (sBCCs) that occurred in four patients. All lesions were treated with topical ALA patches. A complete response of all sBCCs was achieved at week 24 after treatment. Our study suggests that ALA patches for sBCCs have good efficacy rates and excellent safety profile.
Inglese
De Luca, E. V., Tambone, S., Catapano, S., Fossati, B., Peris, K., Photodynamic therapy with 5-aminolevulinate patch for the treatment of superficial basal cell carcinomas, <>, 2020; 33 (6): e14518-N/A. [doi:10.1111/dth.14518] [http://hdl.handle.net/10807/168702]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10807/168702
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact